Literature DB >> 12545556

Quantitative detection of low-copy-number mRNAs differing at single nucleotide positions.

J Stenman1, S Lintula, O Rissanen, P Finne, J Hedström, A Palotie, A Orpana.   

Abstract

Accurate analysis of mRNA expression levels of SNPs, highly homologous genes, and splicing variants requires techniques capable of quantifying low-copy-number mRNAs differing at single nucleotide positions. We have used an RT-PCR-based technique based on co-amplification of closely related target mRNA transcripts and assessed the effect of the stochastic distribution of low-copy-number templates on sampling variation when quantifying rare mRNA transcripts. The technique was optimized for maximal sensitivity to enable the analysis of samples containing a subpopulation of target cells and small microdissected samples. We demonstrate that the input level of template molecules is a critical determinant of the achievable assay precision. A minimum of approximately 50 molecules of template is required to discriminate between 2-fold differences in the expression levels of two transcripts. At levels above 1000 molecules of input template, the stochastic effects on sampling variation become negligible.

Mesh:

Substances:

Year:  2003        PMID: 12545556     DOI: 10.2144/03341dd05

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  9 in total

1.  Quantitative evaluation by minisequencing and microarrays reveals accurate multiplexed SNP genotyping of whole genome amplified DNA.

Authors:  Lovisa Lovmar; Mona Fredriksson; Ulrika Liljedahl; Snaevar Sigurdsson; Ann-Christine Syvänen
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

2.  Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study.

Authors:  Max Lataillade; Jennifer Chiarella; Rong Yang; Steven Schnittman; Victoria Wirtz; Jonathan Uy; Daniel Seekins; Mark Krystal; Marco Mancini; Donnie McGrath; Birgitte Simen; Michael Egholm; Michael Kozal
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

3.  Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing.

Authors:  Max Lataillade; Jennifer Chiarella; Rong Yang; Michelle DeGrosky; Jonathan Uy; Daniel Seekins; Birgitte Simen; Elizabeth St John; Elizabeth Moreno; Michael Kozal
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

4.  Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use.

Authors:  Thuy Le; Jennifer Chiarella; Birgitte B Simen; Bozena Hanczaruk; Michael Egholm; Marie L Landry; Kevin Dieckhaus; Marc I Rosen; Michael J Kozal
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

5.  Limitations of mRNA amplification from small-size cell samples.

Authors:  Vigdis Nygaard; Marit Holden; Anders Løland; Mette Langaas; Ola Myklebost; Eivind Hovig
Journal:  BMC Genomics       Date:  2005-10-27       Impact factor: 3.969

6.  A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep Pyrosequencing.

Authors:  Elizabeth P St John; Birgitte B Simen; Gregory S Turenchalk; Michael S Braverman; Isabella Abbate; Jeroen Aerssens; Olivier Bouchez; Christian Gabriel; Jacques Izopet; Karolin Meixenberger; Francesca Di Giallonardo; Ralph Schlapbach; Roger Paredes; James Sakwa; Gudrun G Schmitz-Agheguian; Alexander Thielen; Martin Victor; Karin J Metzner; Martin P Däumer
Journal:  PLoS One       Date:  2016-01-12       Impact factor: 3.240

Review 7.  Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling.

Authors:  Vigdis Nygaard; Eivind Hovig
Journal:  Nucleic Acids Res       Date:  2006-02-09       Impact factor: 16.971

8.  Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China.

Authors:  Zou Xiaobai; Chen Xi; Hongping Tian; Ann B Williams; Honghong Wang; Jianmei He; Jun Zhen; Jennifer Chiarella; Lisebeth A Blake; Gregory Turenchalk; Michael J Kozal
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

9.  Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® System.

Authors:  Ka-Wai Cheung; Qiaoli Peng; Liufen He; Kanru Cai; Qiang Jiang; Boping Zhou; Sabrina Wai-Chi To; Wing-Cheong Yam; Li Liu; Zhiwei Chen; Hui Wang
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.